Propranolol induced chromosomal aberrations in Chinese hamster ovary cell line

Document Type : Original article

Authors

Department of Biology, College of Sciences, Shiraz University, Shiraz 71454, Iran AND Institute of Biotechnology, Shiraz University, Shiraz, Iran

Abstract

Propranolol (PL), a non-selective beta-blocker, is a cardiovascular drug widely used to treat hypertension. The present study was concerned with assessing the cytogenetic effects of this drug on Chinese hamster ovary (CHO) cell line. MTT assay was then carried out to determine the cytotoxicity index (IC50) of the drug. The IC50 value of PL was 0.43±0.02 mM. To investigate the clastogenic effects of the drug, chromatid and chromosome breaks and polyploidy in metaphases were analyzed. CHO cells were exposed to different concentrations of the drug (0.1, 0.2, 0.3, 0.4 mM) for 24 hours. Considering that PL has liver metabolism, experiments were carried out in the presence and absence of the metabolic activation system (S9 mix). Mitomycin-C and sodium arsenite were used as positive controls. It was observed that in cells treated with different PL concentrations as 0.1, 0.2 and 0.3 mM, the frequency of chromatid and chromosome breaks as well as polyploidy increased when compared with untreated CHO cells. The addition of S9 mix significantly decreased the chromatid breaks, chromosome breaks and polyploidy compared to the treatment of PL alone. It is concluded that, PL causes chromatid and chromosome aberrations in CHO cell line and the metabolic activation system (S9 mix), playing an important role in drug cytotoxicity reduction.

Keywords

References

1.  Schuller HM, Cole B. Regulation of cell proliferation by beta-adrenergic receptors in a human lung adenocarcinoma cell line. Carcinogenesis 1989;10:1753-1755.
2.  Park PG, Merryman J, Orloff M, Schuller HM. Beta-adrenergic mitogenic signal transduction in peripheral lung adenocarcinoma: implications for individuals with preexisting chronic lung disease. Cancer Res 1995;55:3504-3508.
3. Masur K, Niggemann B, Zanker KS, Entschladen F. Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res 2001;61:2866-2869.
4.  Drell TLt, Joseph J, Lang K, Niggemann B, Zaenker KS, Entschladen F. Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells. Breast Cancer Res Treat 2003;80:63-70.
5.  Yang EV, Sood AK, Chen M, Li Y, Eubank TD, Marsh CB, Jewell S, Flavahan NA, Morrison C, Yeh PE, Lemeshow S, Glaser R. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 2006;66:10357-10364.
6.  Sood AK, Bhatty R, Kamat AA, Landen CN, Han L, Thaker PH, Li Y, Gershenson DM, Lutgendorf S, Cole SW. Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res 2006;12:369-375.
7.  Zhang D, Ma Q, Shen S, Hu H. Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction: the study of beta-adrenoceptor antagonist's anticancer effect in pancreatic cancer cell. Pancreas 2009;38:94-100.
8.  Guo K, Ma Q, Wang L, Hu H, Li J, Zhang D, Zhang M. Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol. Oncol Rep 2009;22:825-830.
9. Zhang D, Ma QY, Hu HT, Zhang M. beta2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NF kappa B and AP-1. Cancer Biol Ther 2010;10:19-29.
10. Liao X, Che X, Zhao W, Zhang D, Bi T, Wang G. The beta-adrenoceptor      antagonist, propranolol, induces human gastric cancer cell apoptosis and cell   cycle arrest via inhibiting nuclear factor kappa B signaling. Oncol Rep 2010;24: 1669-1676.
11. Kastelova A, Dimova S, Nemery B. Propranolol cytotoxicity in rat and human  lung in vitro. Methods Find Exp Clin Pharmacol 2003;25:509-515.
12. Hajighasemi F, Mirshafiey A. In vitro sensitivity of leukemia cells to Propranolol. J Clin Med Res 2009;1:144-149.
13. Cheong HI, Johnson J, Cormier M, Hosseini K. In vitro cytotoxicity of eight beta-blockers in human corneal epithelial and retinal pigment epithelial cell lines: comparison with epidermal keratinocytes and dermal fibroblasts. Toxicol In Vitro 2008;22:1070-1076.
14. Ji Y, Li K, Xiao X, Zheng S, Xu T, Chen S. Effects of propranolol on the proliferation and apoptosis of hemangioma-derived endothelial cells. J Pediatr Surg 2012;47:2216-2223.
15. Aruna N,KrishnamurthyNB.Mutagenic evaluation of propranolol in somatic and germ cells of mice. Mutat Res 1986;173:207-210.
16. Benish M, Bartal I, Goldfarb Y, Levi B, Avraham R, Raz A, Ben-Eliyahu S. Perioperative use of beta-blockers and COX-2 inhibitorsmay improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol 2008;15: 2042-2052.
17. Nguyen LP, Omoluabi O, Parra S, Frieske JM, Clement C, Ammar-Aouchiche Z, Ho SB, Ehre C, Kesimer M, Knoll BJ, Tuvim MJ, Dickey BF, Bond RA. Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model. Am J Respir Cell Mol Biol 2008;38:256-262.
18. Kato H, Kawaguchi M, Inoue S, Hirai K, Furuya H. The effects  of  beta-adrenoceptor antagonists on proinflammatory cytokine concentrations after subarachnoid hemorrhage in rats. Anesth Analg 2009;108:288-295.
19. Starkey E, Shahidullah H. Propranolol for infantile haemangiomas: a review. Arch Dis Child 2011;96:890-893.
20. Liu Y, Peterson D.A, Kimura H, Schubert D. Mechanism of cellular 3- (4,5-Dimethylthiazol -2 -yl)-2,5-Diphenyltetrazolium Bromide (MTT) reduction. J Neurochem 1997;69:581-593.
 21. Mahata J, Ghosh P, Sarkar JN, Ray K, Natarajan AT, Giri AK. Effect of sodium  arsenite on peripheral lymphocytes in vitro: individual susceptibility among a population exposed to arsenic through the drinking water. Mutagenesis 19, 223-229.
 22. Celikler S, Yildiz G, Vatan O, Bilaloglu R. In vitro antigenotoxicity of Ulva rigida C. Agardh (Chlorophyceae) extract against induction of chromosome aberration, sister chromatid exchange and micronuclei by mutagenic agent MMC. Biomed Environ Sci 2008;21:492-498.
 23. Samuel TA, Akande IS, Ebuehi OA. Protective role of the methanolic extract of Icacina trichantha on sodium arsenite induced genotoxicity and hepatotoxicity. Nig Q J Hosp Med 2011;21:262-266.
 24. Sulaiman GM. Role of caffeic acid phenethyl ester on mitomycin C induced clastogenesis: analysis of chromosome aberrations, micronucleus, mitotic index and adenosine deaminase activity in vivo. J Appl Genet 2012;53:213-219.
25. Chakraborty T, De M. Clastogenic effects of inorganic arsenic salts on human chromosomes in vitro. Drug Chem Toxicol 2009;32:169-173.
26. Saliva M, Gaspar J, Silva I, Leão D, Rueff J. Mechanisms of induction of chromosomal aberrations by hydroquinone in V79 cells. Mutagenesis 2003;6:491-496.
27. Chlopkiewicz B. Influence of metabolic activation on the induction of micronuclei by antihypertensive drugs in L929 cells. Arch Toxicol 2011;74:794-798.
28. Hajighasemi F, Mirshafiey A. Propranolol effect on proliferation and vascular endothelial growth factor secretion in human immunocompetent cells. J Clin Med Res 2010;2:22-27.
29. Lee JW, Shahzad MM, Lin YG, Armaiz-Pena G, Mangala LS, Han HD, Kim HS, Nam EJ, Jennings NB, Halder J, Nick AM, Stone RL, Lu C, Lutgendorf SK, Cole SW, Lokshin AE, Sood AK. Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res 2009;15:2695-2702.
30. Natecz-Jawecki G, Wojcik T, Sawiciki J. Evaluation of in vitro biotransformation of propranolol with HPLC, MS/MS, and two bioassays. Environ Toxicol 2008;23:52-58.
31. Mcginnity DF, Parker AJ, Soars M, Riley RJ. Automated definition of the enzymology of drug oxidation by the major human drug metabolizing cytochrome P450s. Drug Metabol Disp 2000;28:1327-1334.
32. Schoenfeld N, Epstein O, Nemesh L, Rosen M, Atsmon A. Effects of propranolol during pregnancy and development of rats. I. Adverse effects during pregnancy. Pediatr Res 1978;12:747-750.
33. Fraysse B, Mons R, Garric J. Development of a zebrafish 4-day embryo-larval bioassay to assess toxicity of chemicals. Ecotoxicol Environ Saf 2006;63:253-267.
Molecular Biology Research Communications
Volume 2, 1-2 - Serial Number 1
April 2013
Pages 11-18

Files

Share

How to cite

Statistics